-
公开(公告)号:US20230158017A1
公开(公告)日:2023-05-25
申请号:US18056975
申请日:2022-11-18
IPC分类号: A61K31/485 , C07D211/62 , C07D217/04 , C07D221/22 , C07D221/28 , C07D223/04 , C07D401/12 , C07D405/12 , C07D489/00 , C07D489/09
CPC分类号: A61K31/485 , C07D211/62 , C07D217/04 , C07D221/22 , C07D221/28 , C07D223/04 , C07D401/12 , C07D405/12 , C07D489/00 , C07D489/09
摘要: The present application relates methods for treating a depressive symptom comprising administering an effective amount of a μ opioid receptor agonist or a pharmaceutically acceptable salt thereof to a subject in need thereof. Non-limiting examples of such agonist include the compounds of Formulas I, II, III, and IV, as well as the compounds of Table A.
-
公开(公告)号:US10035807B2
公开(公告)日:2018-07-31
申请号:US15557311
申请日:2016-03-11
申请人: SIEGFRIED AG
发明人: Stefan Sahli , Beat Theodor Weber
IPC分类号: C07D489/12
CPC分类号: C07D489/12 , C07D489/09 , Y02P20/55
摘要: The present invention relates to a method of preparing a compound of Formula II-a′ or Formula II-b′, wherein RI represents hydrogen or a linear, branched and/or cyclic alkyl or alkenyl group having 1 to 10 carbon atoms;RII represents a linear, branched and/or cyclic alkyl or alkenyl group having 1 to 10 carbon atoms; RIII represents hydrogen or a linear, branched and/or cyclic alkyl or alkenyl group having 1 to 10 carbon atoms or a linear, branched and/or cyclic alkoxy group having 1 to 10 carbon atoms; RIV represents hydrogen or a linear, branched and/or cyclic alkyl group having 1 to 10 carbon atoms or an optionally substituted aryl or alkylaryl group having 6 to 40 carbon atom or acetyl or silyl or a protective group; and RV represents hydrogen or a methyl group; wherein RI and RII are different from each other.
-
公开(公告)号:US09656961B2
公开(公告)日:2017-05-23
申请号:US14286499
申请日:2014-05-23
IPC分类号: A61K31/44 , C07D221/28 , A61K31/485 , C07D211/62 , C07D217/04 , C07D221/22 , C07D223/04 , C07D401/12 , C07D405/12 , C07D489/00 , C07D489/09
CPC分类号: A61K31/485 , C07D211/62 , C07D217/04 , C07D221/22 , C07D221/28 , C07D223/04 , C07D401/12 , C07D405/12 , C07D489/00 , C07D489/09
摘要: The present application relates methods for treating a depressive symptom comprising administering an effective amount of a μ opioid receptor agonist or a pharmaceutically acceptable salt thereof to a subject in need thereof. Non-limiting examples of such agonist include the compounds of Formulas I, II, III, and IV, as well as the compounds of Table A.
-
4.
公开(公告)号:US20110306603A1
公开(公告)日:2011-12-15
申请号:US13215392
申请日:2011-08-23
申请人: Mark P. Wentland
发明人: Mark P. Wentland
IPC分类号: A61K31/485 , C07D401/12 , C07D489/08 , C07D489/12 , C07D471/08 , C07D211/34 , C07D409/06 , C07D403/10 , C07D241/04 , C07D223/04 , C07D471/04 , A61K31/451 , A61K31/4535 , A61K31/496 , A61K31/495 , A61K31/4725 , A61K31/55 , A61K31/4745 , A61P29/00 , A61P17/04 , A61P1/12 , A61P1/00 , A61P3/04 , A61P11/00 , A61P25/08 , A61P25/30 , C07D221/26
CPC分类号: C07D471/04 , C07D211/32 , C07D221/22 , C07D221/26 , C07D221/28 , C07D223/04 , C07D241/04 , C07D401/12 , C07D403/10 , C07D489/00 , C07D489/08 , C07D489/09 , C07D489/12
摘要: 8-Substituted-2,6-methano-3-benzazocines of general structure are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications.
摘要翻译: 通用结构的8-取代-2,6-亚甲基-3-苯并吖嗪可用作止痛剂,抗腹泻剂,抗惊厥药,镇咳药和抗瘾药物。
-
5.
公开(公告)号:US20230391788A1
公开(公告)日:2023-12-07
申请号:US18250853
申请日:2021-10-27
发明人: Kunal SAXENA , Aarkarsh SAXENA
IPC分类号: C07D489/09 , A61K47/44 , A61K47/10 , A61K9/00 , A61K47/34 , A61K31/485
CPC分类号: C07D489/09 , A61K47/44 , A61K47/10 , A61K9/0019 , A61K47/34 , A61K31/485
摘要: Disclosed herein is an improved process for preparation of naltrexone decanoate under a monophasic medium using a single solvent by esterifying naltrexone with a decanoyl chloride in the presence of an organic base, wherein the solvent is preferably cyclo-pentyl-methyl-ether (CPME) which is non-toxic in nature. The invention further discloses the elimination of an impurity bis-decanoyl naltrexone obtained during the preparation of naltrexone decanoate by preparing acid addition salts of naltrexone decanoate and reconverting into naltrexone decanoate from its acid addition salts by neutralizing using a base in the presence of suitable solvent to obtain naltrexone decanoate with a purity of more than 99% The invention also discloses pharmaceutical composition of naltrexone decanoate with at least one pharmaceutically acceptable excipient and method of use of naltrexone decanoate for the treatment of opioid dependence, alcohol dependence for a period of 7 days to 90 days in a patient in need thereof.
-
公开(公告)号:US20170216279A1
公开(公告)日:2017-08-03
申请号:US15489377
申请日:2017-04-17
IPC分类号: A61K31/485
CPC分类号: A61K31/485 , C07D211/62 , C07D217/04 , C07D221/22 , C07D221/28 , C07D223/04 , C07D401/12 , C07D405/12 , C07D489/00 , C07D489/09
摘要: The present application relates methods for treating a depressive symptom comprising administering an effective amount of a μ opioid receptor agonist or a pharmaceutically acceptable salt thereof to a subject in need thereof. Non-limiting examples of such agonist include the compounds of Formulas I, II, III, and IV, as well as the compounds of Table A.
-
公开(公告)号:US08541586B2
公开(公告)日:2013-09-24
申请号:US13215392
申请日:2011-08-23
申请人: Mark P. Wentland
发明人: Mark P. Wentland
IPC分类号: C07D211/08 , C07D211/06
CPC分类号: C07D471/04 , C07D211/32 , C07D221/22 , C07D221/26 , C07D221/28 , C07D223/04 , C07D241/04 , C07D401/12 , C07D403/10 , C07D489/00 , C07D489/08 , C07D489/09 , C07D489/12
摘要: 8-Substituted-2,6-methano-3-benzazocines of general structure are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications.
-
公开(公告)号:US20110112297A1
公开(公告)日:2011-05-12
申请号:US13000200
申请日:2009-06-19
IPC分类号: C07D489/08 , C07F7/18
CPC分类号: C07D489/08 , C07D489/09
摘要: The present invention relates to morphinan derivatives and preparation methods thereof, especially to ketal hydroxyl protected compounds of morphinan derivatives and preparation method thereof, and to a method for preparing corresponding alkylated morphinan derivatives by using the ketal hydroxyl protected compounds as intermediates, and more especially to a ketal hydroxyl protected compound of methylnaltrexone as intermediate for preparing methylnaltrexone and a method for preparing methylnaltrexone through said intermediate.
摘要翻译: 本发明涉及吗啡喃衍生物及其制备方法,尤其涉及缩酮羟基保护的吗啡喃衍生物化合物及其制备方法,以及通过使用缩酮羟基保护的化合物作为中间体制备相应的烷基化吗啡喃衍生物的方法,更具体地涉及 作为制备甲基纳曲酮的中间体的甲基纳曲酮的缩酮羟基保护的化合物和通过所述中间体制备甲基纳曲酮的方法。
-
9.
公开(公告)号:US09156821B2
公开(公告)日:2015-10-13
申请号:US14529832
申请日:2014-10-31
发明人: Mark P. Wentland
IPC分类号: C07D211/22 , C07D211/14 , C07D403/10 , C07D221/22 , C07D221/26 , C07D221/28 , C07D489/00 , C07D489/12 , C07D401/12 , C07D489/08 , C07D489/09 , C07D211/32 , C07D223/04 , C07D241/04 , C07D471/04
CPC分类号: C07D471/04 , C07D211/32 , C07D221/22 , C07D221/26 , C07D221/28 , C07D223/04 , C07D241/04 , C07D401/12 , C07D403/10 , C07D489/00 , C07D489/08 , C07D489/09 , C07D489/12
摘要: 8-Substituted-2,6-methano-3-benzazocines of general structure are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications.
摘要翻译: 通用结构的8-取代-2,6-亚甲基-3-苯并吖嗪可用作止痛剂,抗腹泻剂,抗惊厥药,镇咳药和抗瘾药物。
-
公开(公告)号:US20150072971A1
公开(公告)日:2015-03-12
申请号:US14286499
申请日:2014-05-23
发明人: Laura Cook Blumberg , Dan Deaver , David Eyerman , Thomas Wynn
IPC分类号: C07D221/28 , C07D221/22 , C07D401/12 , C07D489/09 , C07D211/62 , C07D217/04 , C07D223/04 , C07D405/12 , C07D489/00
CPC分类号: A61K31/485 , C07D211/62 , C07D217/04 , C07D221/22 , C07D221/28 , C07D223/04 , C07D401/12 , C07D405/12 , C07D489/00 , C07D489/09
摘要: The present application relates methods for treating a depressive symptom comprising administering an effective amount of a μ opioid receptor agonist or a pharmaceutically acceptable salt thereof to a subject in need thereof. Non-limiting examples of such agonist include the compounds of Formulas I, II, III, and IV, as well as the compounds of Table A.
摘要翻译: 本申请涉及治疗抑郁症状的方法,包括向有需要的受试者施用有效量的μ阿片受体激动剂或其药学上可接受的盐。 这种激动剂的非限制性实例包括式I,II,III和IV的化合物,以及表A的化合物。
-
-
-
-
-
-
-
-
-